ChromaVision Medical Systems Inc., a San Juan Capistrano maker of medical imaging systems, said Monday that it has adopted a so-called poison-pill plan, typically a move designed to fend off unwanted takeover bids.
Company officials said the move was precautionary and they are not aware of any actual threat. The shareholder-rights plan was adopted "to provide the board of directors with adequate time and a full opportunity to consider any and all alternatives in the event of such hostile action," said Douglas S. Harrington, ChromaVision's chief executive.
